In the latest trading session, 2.23 million Morphosys AG ADR (NASDAQ:MOR) shares changed hands as the company’s beta touched 0.88. With the company’s most recent per share price at $4.53 changed hands at -$1.33 or -22.70% at last look, the market valuation stands at $619.21M. MOR’s current price is a discount, trading about -91.39% off its 52-week high of $8.67. The share price had its 52-week low at $3.17, which suggests the last value was 30.02% up since then. When we look at Morphosys AG ADR’s average trading volume, we note the 10-day average is 0.74 million shares, with the 3-month average coming to 312.91K.

Analysts gave the Morphosys AG ADR (MOR) stock a consensus recommendation rating of an Overweight, calculated at a mean rating of 1.73. If we narrow down to specifics, the data shows that 1 out of 11 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended MOR as a Hold, 8 felt it is a Buy and 0 rated the stock as Underweight. Morphosys AG ADR’s EPS for the current quarter is expected to be -$1.98.

Morphosys AG ADR (NASDAQ:MOR) trade information

Instantly MOR was in red as seen in intraday trades today. With action -39.44%, the performance over the past five days has been red. The drop to weekly highs of 7.60 on Monday, 11/20/23 subtracted -22.70% to the stock’s daily price. The company’s shares are showing year-to-date upside of 26.54%, with the 5-day performance at -39.44% in the red. However, in the 30-day time frame, Morphosys AG ADR (NASDAQ:MOR) is -33.67% down. Looking at the short shares, we see there were 61960.0 shares sold at short interest cover period of 0.24 days.

The consensus price target for the stock as assigned by Wall Street analysts is $10.31, meaning bulls need an upside of 56.06% from its recent market value. According to analyst projections, MOR’s forecast low is $2.73 with $17.00 as the target high. To hit the forecast high, the stock’s price needs a -275.28% plunge from its current level, while the stock would need to tank 39.74% for it to hit the projected low.

Morphosys AG ADR (MOR) estimates and forecasts

Data shows that the Morphosys AG ADR share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -29.44% over the past 6 months, a -75.86% in annual growth rate that is considerably lower than the industry average of 14.80%. Moreover, analysts have looked to lower expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Morphosys AG ADR will fall -175.90%, while the growth in revenue is estimated to hit 30.60% for the next quarter. Year-over-year growth is forecast to reach -13.10% down from the last financial year.

Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of $63.23 million. 2 analysts are of the opinion that Morphosys AG ADR’s revenue for the quarter ending Mar 2024 will be $59.79 million. The company’s revenue for the corresponding quarters a year ago was $88.31 million and $67.97 million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -28.40%. The estimates for the next quarter sales put growth at -12.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -11.32%. The 2023 estimates are for Morphosys AG ADR earnings to decrease by -68.09%.

MOR Dividends

Morphosys AG ADR is expected to release its next quarterly earnings report in December.

Morphosys AG ADR (NASDAQ:MOR)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.00% of Morphosys AG ADR shares while 9.90% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 9.90%. There are 9.90% institutions holding the Morphosys AG ADR stock share, with T. Rowe Price Investment Management, Inc. the top institutional holder. As of Jun 29, 2023, the company held 5.67% of the shares, roughly 7.76 million MOR shares worth $57.97 million.

Logos Global Management LP holds the second largest percentage of outstanding shares, with 0.88% or 1.2 million shares worth $8.96 million as of Jun 29, 2023.

Among Mutual Funds, the top two as of Jun 29, 2023 were Price (T.Rowe) Small Cap Stock Fund and Price (T.Rowe) Small-Cap Value Fund. With 2.23 million shares estimated at $16.62 million under it, the former controlled 1.63% of total outstanding shares. On the other hand, Price (T.Rowe) Small-Cap Value Fund held about 1.14% of the shares, roughly 1.55 million shares worth around $11.61 million.